3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
24
Colonic Polyps
15
Adenoma
14
Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
5
Polyps
4
Pain
4
Gastrointestinal Neoplasms
4
Disease
4
Adenomatous Polyps
3
Stomach Neoplasms
2
Peptic Ulcer
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Turcot syndrome
1
Tuberculosis
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Neoplasms
1
Rectal Diseases
1
Predictive Cancer Model
1
Personal Satisfaction
1
Patient Satisfaction
1
Pathologic Complete Response
1
Interventions
pembrolizumab
4
Nivolumab
3
toripalimab
2
sintilimab
2
Neoadjuvant Therapy
2
Celecoxib
2
tislelizumab
1
spartalizumab
1
relatlimab
1
regorafenib
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
denileukin diftitox
1
danvatirsen
1
camrelizumab
1
avelumab
1
atezolizumab
1
XELOX
1
Taxes
1
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Ipilimumab
1
Induction Chemotherapy
1
Immunotherapy
1
Immunoglobulin G
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Turcot syndrome
×
Colonoscopy
×
Clear all
NCT07360834
2026-01-23
PREDI-LYNCH
UNICANCER
Phase NA
Not yet recruiting
2,000 enrolled